Braun Stacey Associates Inc. bought a new stake in Lumentum Holdings Inc. (NASDAQ:LITE – Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 92,957 shares of the technology company’s stock, valued at approximately $15,125,000.
Several other large investors have also recently made changes to their positions in the company. Leeward Investments LLC MA grew its holdings in shares of Lumentum by 14.8% during the second quarter. Leeward Investments LLC MA now owns 516,431 shares of the technology company’s stock worth $49,092,000 after buying an additional 66,541 shares in the last quarter. Schroder Investment Management Group lifted its stake in shares of Lumentum by 1.9% in the second quarter. Schroder Investment Management Group now owns 881,813 shares of the technology company’s stock worth $83,825,000 after buying an additional 16,200 shares in the last quarter. Assenagon Asset Management S.A. boosted its position in Lumentum by 198.2% during the third quarter. Assenagon Asset Management S.A. now owns 123,229 shares of the technology company’s stock worth $20,051,000 after acquiring an additional 81,906 shares during the last quarter. Northwest & Ethical Investments L.P. grew its stake in Lumentum by 45.7% during the 2nd quarter. Northwest & Ethical Investments L.P. now owns 10,200 shares of the technology company’s stock valued at $966,000 after acquiring an additional 3,200 shares in the last quarter. Finally, Corton Capital Inc. purchased a new stake in Lumentum during the 2nd quarter valued at about $272,000. 94.05% of the stock is currently owned by hedge funds and other institutional investors.
Lumentum Price Performance
NASDAQ:LITE opened at $368.59 on Friday. Lumentum Holdings Inc. has a 52 week low of $45.65 and a 52 week high of $401.60. The stock’s fifty day moving average is $295.30 and its two-hundred day moving average is $185.52. The company has a market capitalization of $26.13 billion, a P/E ratio of 247.38 and a beta of 1.51. The company has a quick ratio of 1.02, a current ratio of 1.37 and a debt-to-equity ratio of 2.77.
Wall Street Analysts Forecast Growth
A number of research firms have weighed in on LITE. B. Riley raised their target price on shares of Lumentum from $83.00 to $147.00 and gave the stock a “neutral” rating in a research note on Wednesday, November 5th. Wall Street Zen downgraded Lumentum from a “buy” rating to a “hold” rating in a research report on Saturday, November 1st. JPMorgan Chase & Co. boosted their price objective on Lumentum from $145.00 to $185.00 and gave the stock an “overweight” rating in a research note on Thursday, October 16th. Rosenblatt Securities raised their target price on Lumentum to $380.00 and gave the stock a “buy” rating in a research note on Thursday, December 4th. Finally, Wolfe Research reiterated an “outperform” rating and set a $240.00 price target on shares of Lumentum in a report on Wednesday, November 5th. Two analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and six have issued a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $222.13.
View Our Latest Report on Lumentum
Insider Buying and Selling at Lumentum
In other Lumentum news, Director Julia Suzanne Johnson sold 10,000 shares of the firm’s stock in a transaction that occurred on Monday, November 10th. The shares were sold at an average price of $270.39, for a total value of $2,703,900.00. Following the completion of the transaction, the director owned 12,037 shares of the company’s stock, valued at $3,254,684.43. This trade represents a 45.38% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Director Pamela Fletcher sold 3,421 shares of the business’s stock in a transaction on Wednesday, November 19th. The stock was sold at an average price of $273.53, for a total transaction of $935,746.13. Following the completion of the transaction, the director owned 10,561 shares of the company’s stock, valued at approximately $2,888,750.33. This trade represents a 24.47% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 28,612 shares of company stock valued at $7,317,398. Corporate insiders own 0.43% of the company’s stock.
About Lumentum
Lumentum Holdings Inc, headquartered in San Jose, California, is a leading provider of photonic technologies that enable high-speed optical communication networks and advanced industrial applications. The company designs and manufactures a broad range of lasers, optical modules and subsystems tailored to the evolving requirements of telecommunications carriers, cloud data centers and enterprise networking.
Its core product portfolio includes tunable and fixed-wavelength laser transmitters, coherent optical engines, transceivers for long-haul, metro and data center interconnects, as well as test and measurement instruments.
Recommended Stories
- Five stocks we like better than Lumentum
- GOLD ALERT
- If You Keep Cash In A U.S. Bank Account… Read This NOW
- The $100 Trillion AI Story No One Is Telling You
- Bombshell Exposé on China Strikes
- Do not delete, read immediately
Want to see what other hedge funds are holding LITE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lumentum Holdings Inc. (NASDAQ:LITE – Free Report).
Receive News & Ratings for Lumentum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lumentum and related companies with MarketBeat.com's FREE daily email newsletter.
